| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko, Tsukui-gun, Kanagawa 199-01 [K. M., R. T., M. Y., D. M.], and Research Development Corporation of Japan, Nissho-Building, 1424, Koishikawa 4-chome, Bunkyo-ku, Tokyo 112 [D. M.], Japan
The cytotoxic activity of polymorphonuclear leukocytes (PMN) against tumor cells induced in vitro by antitumor immunomodulators was examined by a 51Cr release cytotoxicity assay. Among 28 immunomodulators and other agents thus far tested, only ß-1,3-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, Bacillus Calmette-Guérin, Propionibacterium acnes, zymosan A, and Nocardia cell wall skeleton were found to cause induction. The cytotoxic activity of PMN with the ß-1,3-glucan was very high, almost 100% cytolysis being observed at an effector:target ratio as low as 3. The other four potent immunomodulators had effects very similar to that of the ß-1,3-glucan. All five tumor cell lines tested, MM46, MM48, MH134, EL-4, and YAC-1, were lysed, whereas normal spleen and thymus cells and PMN were not. Of four types of effector cells tested, PMN and casein-induced macrophages were effective, whereas resident macrophages and J774 cells were not effective. The cytotoxic activity of PMN was greater than that of induced macrophages, although both were induced by casein. From results on the polysaccharides tested, a linear ß-1,3-glucan structure and a minimum number average degree of polymerization of 125 of the ß-1,3-glucan seemed to be required for induction of cytotoxicity of PMN. The cytotoxic features of PMN and possible chemical structures of antitumor polysaccharides for induction of cytotoxicity are discussed.
1 This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan.
2 To whom requests for reprints should be addressed.
Received 8/10/84. Revised 11/19/84. Accepted 12/27/84.
This article has been cited by other articles:
![]() |
Y. Sakamoto, H. Watanabe, M. Nagai, K. Nakade, M. Takahashi, and T. Sato Lentinula edodes tlg1 Encodes a Thaumatin-Like Protein That Is Involved in Lentinan Degradation and Fruiting Body Senescence Plant Physiology, June 1, 2006; 141(2): 793 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yan, V. Vetvicka, Y. Xia, A. Coxon, M. C. Carroll, T. N. Mayadas, and G. D. Ross {beta}-Glucan, a ""Specific"" Biologic Response Modifier That Uses Antibodies to Target Tumors for Cytotoxic Recognition by Leukocyte Complement Receptor Type 3 (CD11b/CD18) J. Immunol., September 15, 1999; 163(6): 3045 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Young, J. Ye, D. G. Frazer, X. Shi, and V. Castranova Molecular Mechanism of Tumor Necrosis Factor-alpha Production in 1right-arrow3-beta -Glucan (Zymosan)-activated Macrophages J. Biol. Chem., June 1, 2001; 276(23): 20781 - 20787. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |